Children’s Health in Dallas, Texas announced plans to use Proteus Digital Health’s ingestible medication sensors to track medication adherence in kids with liver and kidney transplants.
Medication adherence is a challenge for many patients for a variety of reasons – complexity of medication regiments, costs, memory, and more all play in to it. That problem is magnified by our (clinicians) lack of awareness of it – we often just don’t know that our patients are, for whatever reason, not taking their medications.
Proteus’ ingestible medication sensor is compounded into a capsule with a medication. When it is swallowed, the sensor sends a signal to a body-worn patch as it dissolves in the stomach. That patch can then pass on that signal, indicating the medication was taken, to Proteus’ cloud based system for monitoring and, more importantly, intervention if medications aren’t being taken as expected.
That’s particularly critical for transplant medications, where immunosuppressants mean the difference between graft survival (which often equals patient survival) and graft failure. In kids, especially as they hit their more rebellious years, that can be a particularly serious challenge.
We recently covered another health system that plans to use the Proteus’ ingestible sensor in patients with refractory hypertension. As with that program, the impact of using these sensors isn’t simply from knowing if a pill was missed. It’s in the clinical processes & support that (hopefully) leap into action when that medication is missed to understand why that happened and work with the patient to address whatever barriers they are facing.
Children’s Health plans to start with a cohort of 75 kids but reportedly plans to expand beyond that. Hopefully, as these clinical early adopters get started, we’ll see some data from their experiences to see if the Proteus’ sensors deliver an impact that justifies the costs.
Source: Dallas Healthcare Daily